The British Generic Manufacturers Association (BGMA) and Department of Health have announced a joint initiative to explore potential challenges to the sustainability of the generic pharmaceutical industry in England. Based on proposals in an Action Plan from the BGMA, the Department will facilitate conversations across government to understand issues and to identify where appropriate action can be taken. The initiative was announced at the BGMA’s Annual General Meeting, which was attended by Health Minister, Lord Howe.

  Michael Cann with Lord Howe at the BGMA meeting.

Click this link to read the full BGMA Press Release (PDF)